Celuarity is a commercial stage cellular therapeutic company focusing on allogenic cellular therapies. Celularity is headquartered in Warren, New Jersey and was founded in 2016 by Carlos Ramirez, Jerome Zeldis, Jodi Gurney, John R Haines, Robert Hariri, and Steven French.
On September 28, 2017 Celularity announced closing a venture round raising $40 million in capital from undisclosed investors.
On February 15, 2018 Celularity completed their second round of venture funding with $250 million in capital from Colgene (lead investor), United Therapeutics, Sorrento Therapeutics, Section 32, Human Longetivity, Celgene, Bill Maris, and Tony Robbins.
Timeline
On February 15, 2018 Celularity completed their second round of venture funding with $250 million in capital from Colgene (lead investor), United Therapeutics, Sorrento Therapeutics, Section 32, Human Longetivity, Celgene, Bill Maris, and Tony Robbins.
On September 28, 2017 Celularity announced closing a venture round raising $40 million in capital from undisclosed investors.
Celularity is headquartered in Warren, New Jersey and was founded in 2016 by Carlos Ramirez, Jerome Zeldis, Jodi Gurney, John R Haines, Robert Hariri, and Steven French.
Funding rounds
People
Further reading
Celularity Announces $250M in Funding to Deliver Treatments for Cancer, Inflammatory and Degenerative Diseases, and Functional Regeneration
Celularity
Web